Stock Events

Stock Events

Cns Pharmaceuticals (BE50.F) Q2 2026 Earnings

14MayConfirmed

Q2 2025

Q3 2025

Q4 2025

Q2 2026

-21.45

-15.83

-10.22

-4.6

Details

Expected EPS

-4.603701

Actual EPS

-6.25829

Surprise EPS

-1.65

Surprise Percent

+35.94%

Description

Cns Pharmaceuticals (BE50.F) has reported earnings of -6.25829 per share for Q2 2026.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.